ストックスクリーナーアプリを入手
3.61
14.24%
0.45
前日終値:
$3.16
開ける：
$3.16
24時間の取引高:
483.25K
Relative Volume:
1.61
時価総額：
$186.23M
収益：
$44.12M
当期純損益:
$-156.25M
株価収益率:
-0.8741
EPS:
-4.13
ネットキャッシュフロー:
$-154.61M
1週間 パフォーマンス:
+2.56%
1か月 パフォーマンス:
-30.71%
6か月 パフォーマンス:
-20.66%
1年 パフォーマンス:
+107.47%
1日の値動き範囲:
$3.16
$3.7294
1週間の範囲:
$3.02
$3.7294
52週間の値動き範囲:
$1.675
$6.40
2 Seventy Bio Inc Stock (TSVT) Company Profile
TSVT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| TSVT | 3.61 | 186.23M | 44.12M | -156.25M | -154.61M | -4.13 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-13 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-07-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-31 | 開始されました | Guggenheim | Buy |
| 2022-05-02 | 開始されました | Goldman | Buy |
| 2022-02-10 | 開始されました | SVB Leerink | Outperform |
| 2022-01-06 | 開始されました | Cowen | Outperform |
| 2021-11-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-11-08 | 開始されました | Morgan Stanley | Overweight |
| 2021-11-08 | 開始されました | Wedbush | Outperform |
すべてを表示
2 Seventy Bio Inc (TSVT) 最新ニュース
Layoff Tracker: Sonata Therapeutics Laying Off 20 Employees, Changing Leadership - BioSpace
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results - GlobeNewswire
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire
2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Exchange Traded Concepts LLC - Defense World
BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) - Yahoo Finance
Dimensional Fund Advisors LP Sells 24,371 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
BMS and 2seventy bio Axe Trial for Ide-Cel in Newly Diagnosed Multiple Myeloma - CGTLive™
2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance - Business Wire
Seven Eight Capital LP Makes New $197,000 Investment in Beyond, Inc. (NYSE:BYON) - Defense World
Q&A: Athens legends Five Eight and the makers of their new documentary film, "Weirdo" - Online Athens
Four killed, dozens injured in Alabama mass shooting - Daily Sun
Seven Eight Capital LP Sells 536 Shares of Dell Technologies Inc. (NYSE:DELL) - Defense World
Four dead, 17 others shot in Birmingham mass shooting - WJLA
Five Below, Inc. (NASDAQ:FIVE) Stake Raised by Teca Partners LP - Defense World
Four killed, over 20 injured in Birmingham, Alabama shooting - Thaiger World
At least four dead and dozens injured in shootout with multiple assailants in the United States - Top Buzz Times
Four people dead and dozens injured in US mass shooting horror - Express
Analyst bullish on Tectonic's TX45 ahead of full trial results presentation at AHA - Investing.com India
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire
Hedge fund Two Sigma in settlement talks with US SEC, WSJ reports - XM
US data: key federal and state updates (13 – 19 Sep) - Lexology
The LYCRA Company Presents Seminars on Sustainable Elastane Solutions at the 63rd Dornbirn Global Fiber Congress - Via Ritzau
Jessica Snow Sells 7,816 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) Stock - Defense World
2seventy bio, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress - Business Wire
2seventy bio to Report Second Quarter 2024 Financial Results on August 7, 2024 - Business Wire
Biopharma Layoff Tracker 2024: Cue, Anokion, GlycoMimetics and More Cut Staff - BioSpace
Annovis Bio Inc (ANVS-N) QuotePress Release - The Globe and Mail
2 Seventy Bio Inc (TSVT) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
2.08%
大文字化:
|
ボリューム (24 時間):